BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Capital Reinvestment Ratio
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Capital Reinvestment Ratio of 0.83x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs149.66 Million) in capital expenditures (Rs123.88 Million). See BALAXI PHARMACEUTICALS LIMITED balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BALAXI PHARMACEUTICALS LIMITED Capital Reinvestment Ratio (2015–2024)
This chart tracks BALAXI PHARMACEUTICALS LIMITED's Capital Reinvestment Ratio across 5 annual periods. Check BALAXI PHARMACEUTICALS LIMITED total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for BALAXI PHARMACEUTICALS LIMITED (2015–2024)
Year-by-year Capital Reinvestment Ratio for BALAXI PHARMACEUTICALS LIMITED from 2015 to 2024. For live market cap and broader valuation context, see BALAXI stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | Rs48.66 Million | Rs15.69 Million | ▼ -86.9% |
| 2023 | 2.47x | Rs60.75 Million | Rs149.80 Million | ▲ +207.9% |
| 2022 | 0.80x | Rs341.44 Million | Rs273.44 Million | ▼ -99.9% |
| 2021 | 824.65x | Rs31.00K | Rs25.56 Million | ▲ +5861379.5% |
| 2015 | 0.01x | Rs2.11 Million | Rs29.72K | — |